Delving into the Latest Updates on Beijing Union Medical College Hospital, Chinese Academy of Medical Sciences with Synapse

Overview

Tags

Neoplasms

Infectious Diseases

Respiratory Diseases

Small molecule drug

Diagnostic radiopharmaceuticals

Prophylactic vaccine

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	13
Infectious Diseases	7
Endocrinology and Metabolic Disease	3
Nervous System Diseases	2
Hemic and Lymphatic Diseases	2
Immune System Diseases	1

Top 5 Drug Type	Count

Small molecule drug	14
Diagnostic radiopharmaceuticals	3
Prophylactic vaccine	2
mRNA vaccine	2
Peptide Conjugate Radionuclide	1

Top 5 Target	Count

LpxC(UDP-3-O-acyl-N-acetylglucosamine deacetylase)	3
LpxH(Bacterial UDP-diacylglucosamine Pyrophosphohydrolase)	2
AHRR(aryl-hydrocarbon receptor repressor)	1
FLT3 x HDACs x VEGFR2	1
GLP-1R(Glucagon-like peptide 1 receptor)	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 01 Nov 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

2

21

Preclinical

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Compound b1(Chinese Academy of Medical Sciences & Peking Union Medical College) ( LpxC )	Escherichia Coli Infections More	Preclinical
Compound a5(Chinese Academy of Medical Sciences & Peking Union Medical College) ( LpxC )	Escherichia Coli Infections More	Preclinical
Compound b2(Chinese Academy of Medical Sciences & Peking Union Medical College) ( LpxC )	Escherichia Coli Infections More	Preclinical
DL-0410 ( ACHE )	Dementia, Vascular More	Preclinical
CES2 inhibitors(Chinese Academy of Medical Sciences and Peking Union Medical College) ( CES2 )	Colitis, Ulcerative More	Preclinical